Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$177.6M
Prescriptions
11K
$16,657.70 per claim
Patients
1,923
604 prescribers
Total spending, 2024
$177.6M
$92,366.62 per patient
Medicare prescription drug plans paid $177.6M for Winrevair in 2024, for 10,663 prescriptions and refills to 1,923 patients. The average cost per claim was $16,657.70.
California had the highest Medicare cost for Winrevair in 2024: $14.8M for 923 claims, followed by Pennsylvania ($14.6M).
John W McConnell, pulmonary disease in Louisville, KY, had the highest Medicare cost for Winrevair in 2024: 238 claims costing $3.9M.
Winrevair is made by Merck & Co., Inc. (MRK), listed in the Medicare spending data as Merck Sharp & D.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| John W McConnell Louisville, KY | Pulmonary Disease | 238 | 29 | $3.9M |
| Simone Hannah-Clark New York, NY | Nurse Practitioner | 196 | 35 | $3.3M |
| Ali Ataya |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2024 | 604 | 10,663 | 1,923 | $177.6M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Merck Sharp & D MRK |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Critical Care (Intensivists) |
| 205 |
| 43 |
| $3.3M |
| Kishan S Parikh Raleigh, NC | Advanced Heart Failure and Transplant Cardiology | 132 | 19 | $2.5M |
| Jean M Elwing Cincinnati, OH | Pulmonary Disease | 128 | 19 | $2.2M |
| Murali M Chakinala Saint Louis, MO | Pulmonary Disease | 126 | 17 | $2.1M |
| John D Dallas Austin, TX | Pulmonary Disease | 102 | 16 | $2.0M |
| Naomi G Habib Phoenix, AZ | Pulmonary Disease | 137 | 21 | $1.9M |
| Vallerie V McLaughlin Ann Arbor, MI | Cardiology | 108 | 15 | $1.8M |
| Christina M Eagan Gainesville, FL | Nurse Practitioner | 122 | 17 | $1.8M |
| Roberto F Machado Indianapolis, IN | Pulmonary Disease | 105 | 15 | $1.8M |
| Linda M Cadaret Iowa City, IA | Advanced Heart Failure and Transplant Cardiology | 94 | 23 | $1.6M |
| Leslie Spikes Kansas City, KS | Pulmonary Disease | 83 | 15 | $1.5M |
| Jeffrey C Robinson Portland, OR | Pulmonary Disease | 73 | 12 | $1.5M |
| David C Booth Lexington, KY | Cardiology | 73 | Under 11 | $1.4M |
| Brittany Palmer Indiana, PA | Cardiology | 82 | 12 | $1.4M |
| John Kingrey Oklahoma City, OK | Pulmonary Disease | 66 | Under 11 | $1.3M |
| Gavin W Hickey Pittsburgh, PA | Internal Medicine | 61 | Under 11 | $1.3M |
| David S Poch San Diego, CA | Pulmonary Disease | 71 | Under 11 | $1.3M |
| Sophia E Airhart Springfield, MA | Advanced Heart Failure and Transplant Cardiology | 79 | Under 11 | $1.3M |
| Ashwin K Ravichandran Indianapolis, IN | Advanced Heart Failure and Transplant Cardiology | 71 | 14 | $1.3M |
| Roberto J Bernardo Stanford, CA | Pulmonary Disease | 65 | 11 | $1.2M |
| Daniel J Lachant Rochester, NY | Pulmonary Disease | 68 | 11 | $1.2M |
| Thenappan Thenappan Minneapolis, MN | Advanced Heart Failure and Transplant Cardiology | 68 | 14 | $1.2M |
| Angela Kraus Milwaukee, WI | Nurse Practitioner | 80 | 14 | $1.2M |
| 10,663 |
| $177.6M |